CD8A and lung cancer: Thus, high levels of CD8+, CD3+ and CD4+ T lymphocyte infiltration in the TME showed better OS in patients with lung cancer [101], and T helper type 1 (Th1) polarization and consequent CD8+ T-cell activation also correlated with a stronger antitumor immune response [102,103].